CIAM
DRTS icon

Caitong International Asset Management’s Alpha Tau Medical DRTS Stock Holding History

Caitong International Asset Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$481 Buy
+68
New +$480 ﹤0.01% 1661

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Caitong International Asset Management's DRTS Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 68 shares worth $481. The stake represents ﹤0.01% of the portfolio and ranks #1661 among its holdings.

53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Caitong International Asset Management held 68 shares of Alpha Tau Medical worth $481 as of Q1 2026.
  • Alpha Tau Medical was a new Caitong International Asset Management position in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1661 holding.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.